Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Prostate ; 73(16): 1747-60, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24038102

ABSTRACT

BACKGROUND: Androgen signalling through the androgen receptor (AR) plays a critical role in prostate cancer (PCa) initiation and progression. Estrogen in synergy with androgen is essential for cell growth of the normal and malignant prostate. However, the exact role that estrogen and the estrogen receptor play in prostate carcinogenesis remains unclear. We have previously demonstrated the metastasis-promoting effect of an estrogen receptor beta (ERß) agonist (genistein) in a patient-derived PCa xenograft model mimicking localized and metastatic disease. METHODS: To test the hypothesis that the tumor-promoting activity of genistein was due to its estrogenic properties, we treated the xenograft-bearing mice with genistein and an anti-estrogen compound (ICI 182, 780) and compared the differential gene expression using microarrays. RESULTS: Using a second xenograft model which was derived from another patient, we showed that genistein promoted disease progression in vivo and ICI 182, 780 inhibited metastatic spread. The microarray analysis revealed that the metallothionein (MT) gene family was differentially expressed in tumors treated by these compounds. Using qRT-PCR, the differences in expression levels were validated in the metastatic and non-metastatic LTL313 PCa xenograft tumor lines, both of which were originally derived from the same PCa patient. CONCLUSIONS: Together our data provide evidence that genistein stimulates and ICI 182, 780 inhibits metastatic progression, suggesting that these effects may be mediated by ERß signalling.


Subject(s)
Antineoplastic Agents/therapeutic use , Disease Progression , Estradiol/analogs & derivatives , Estrogen Antagonists/therapeutic use , Genistein/therapeutic use , Neoplasm Metastasis/drug therapy , Prostatic Neoplasms/drug therapy , Animals , Antineoplastic Agents/pharmacology , Disease Models, Animal , Estradiol/pharmacology , Estradiol/therapeutic use , Estrogen Antagonists/pharmacology , Estrogen Receptor beta/drug effects , Fulvestrant , Gene Expression Regulation, Neoplastic/drug effects , Genistein/pharmacology , Humans , Male , Metallothionein/genetics , Metallothionein/metabolism , Mice , Mice, Inbred NOD , Mice, SCID , Prostatic Neoplasms/pathology , RNA, Small Interfering/pharmacology , Treatment Outcome , Xenograft Model Antitumor Assays
2.
Immunity ; 37(3): 463-74, 2012 Sep 21.
Article in English | MEDLINE | ID: mdl-22981535

ABSTRACT

Natural helper (NH) cells are innate lymphoid cells (ILCs) that produce T helper-2 (Th2)-cell-type cytokines in the lung- and gut-associated lymphoid tissues. Currently, the lineage relationship between NH cells in different tissues and between NH cells and interleukin-22 (IL-22)-producing retinoic-acid-receptor-related orphan receptor (ROR)γt-positive ILCs is unclear. Here, we report that NH cells express RORα, but not RORγt. RORα-deficient, but not RORγt-deficient, mice lacked NH cells in all tissues, whereas all other lymphocytes, including RORγt(+) ILCs, were unaffected. NH-cell-deficient mice generated by RORα-deficient bone-marrow transplantation had normal Th2 cell responses but failed to develop acute lung inflammation in response to protease allergen, thus confirming the essential role of NH cells in allergic lung inflammation. We have also identified RORα-dependent NH cell progenitors in the bone marrow. Thus, all NH cells belong to a unique RORα-dependent cell lineage separate from other lymphoid cell lineages.


Subject(s)
Bone Marrow Cells/immunology , Nuclear Receptor Subfamily 1, Group F, Member 1/immunology , Pneumonia/immunology , T-Lymphocytes, Helper-Inducer/immunology , Allergens/immunology , Animals , Antigens, Ly/genetics , Antigens, Ly/immunology , Bone Marrow Cells/metabolism , Bone Marrow Transplantation , Cell Lineage/immunology , Cells, Cultured , Female , Flow Cytometry , Interleukin Receptor Common gamma Subunit/genetics , Interleukin Receptor Common gamma Subunit/immunology , Lymphocytes/immunology , Lymphocytes/metabolism , Male , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Nuclear Receptor Subfamily 1, Group F, Member 1/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/immunology , Papain/immunology , Pneumonia/genetics , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-kit/immunology , T-Lymphocytes, Helper-Inducer/metabolism , Th2 Cells/immunology , Th2 Cells/metabolism
3.
Annu Rev Genet ; 46: 21-42, 2012.
Article in English | MEDLINE | ID: mdl-22905872

ABSTRACT

The fact that transposable elements (TEs) can influence host gene expression was first recognized more than 50 years ago. However, since that time, TEs have been widely regarded as harmful genetic parasites-selfish elements that are rarely co-opted by the genome to serve a beneficial role. Here, we survey recent findings that relate to TE impact on host genes and remind the reader that TEs, in contrast to other noncoding parts of the genome, are uniquely suited to gene regulatory functions. We review recent studies that demonstrate the role of TEs in establishing and rewiring gene regulatory networks and discuss the overall ubiquity of exaptation. We suggest that although individuals within a population can be harmed by the deleterious effects of new TE insertions, the presence of TE sequences in a genome is of overall benefit to the population.


Subject(s)
DNA Transposable Elements , Gene Regulatory Networks , Genome, Human , Regulatory Sequences, Nucleic Acid , Transcriptional Activation , Animals , Binding Sites , Epigenesis, Genetic , Evolution, Molecular , Genetic Drift , Genetics, Population , Humans , Mutation , Promoter Regions, Genetic , Repetitive Sequences, Nucleic Acid
4.
PLoS Comput Biol ; 7(5): e1002046, 2011 May.
Article in English | MEDLINE | ID: mdl-21573203

ABSTRACT

Comprising nearly half of the human and mouse genomes, transposable elements (TEs) are found within most genes. Although the vast majority of TEs in introns are fixed in the species and presumably exert no significant effects on the enclosing gene, some markedly perturb transcription and result in disease or a mutated phenotype. Factors determining the likelihood that an intronic TE will affect transcription are not clear. In this study, we examined intronic TE distributions in both human and mouse and found several factors that likely contribute to whether a particular TE can influence gene transcription. Specifically, we observed that TEs near exons are greatly underrepresented compared to random distributions, but the size of these "underrepresentation zones" differs between TE classes. Compared to elsewhere in introns, TEs within these zones are shorter on average and show stronger orientation biases. Moreover, TEs in extremely close proximity (<20 bp) to exons show a strong bias to be near splice-donor sites. Interestingly, disease-causing intronic TE insertions show the opposite distributional trends, and by examining expressed sequence tag (EST) databases, we found that the proportion of TEs contributing to chimeric TE-gene transcripts is significantly higher within their underrepresentation zones. In addition, an analysis of predicted splice sites within human long terminal repeat (LTR) elements showed a significantly lower total number and weaker strength for intronic LTRs near exons. Based on these factors, we selectively examined a list of polymorphic mouse LTR elements in introns and showed clear evidence of transcriptional disruption by LTR element insertions in the Trpc6 and Kcnh6 genes. Taken together, these studies lend insight into the potential selective forces that have shaped intronic TE distributions and enable identification of TEs most likely to exert transcriptional effects on genes.


Subject(s)
DNA Transposable Elements , Introns , Models, Genetic , Terminal Repeat Sequences , Transcription, Genetic , Animals , Computational Biology , Computer Simulation , Databases, Genetic , Ether-A-Go-Go Potassium Channels/genetics , Expressed Sequence Tags , Humans , Male , Mice , Mice, Inbred C57BL , Mutagenesis, Insertional , Mutation , RNA Splicing , TRPC Cation Channels/genetics , TRPC6 Cation Channel
5.
PLoS One ; 4(6): e5761, 2009 Jun 02.
Article in English | MEDLINE | ID: mdl-19488400

ABSTRACT

The human neuronal apoptosis inhibitory protein (NAIP) gene is no longer principally considered a member of the Inhibitor of Apoptosis Protein (IAP) family, as its domain structure and functions in innate immunity also warrant inclusion in the Nod-Like Receptor (NLR) superfamily. NAIP is located in a region of copy number variation, with one full length and four partly deleted copies in the reference human genome. We demonstrate that several of the NAIP paralogues are expressed, and that novel transcripts arise from both internal and upstream transcription start sites. Remarkably, two internal start sites initiate within Alu short interspersed element (SINE) retrotransposons, and a third novel transcription start site exists within the final intron of the GUSBP1 gene, upstream of only two NAIP copies. One Alu functions alone as a promoter in transient assays, while the other likely combines with upstream L1 sequences to form a composite promoter. The novel transcripts encode shortened open reading frames and we show that corresponding proteins are translated in a number of cell lines and primary tissues, in some cases above the level of full length NAIP. Interestingly, some NAIP isoforms lack their caspase-sequestering motifs, suggesting that they have novel functions. Moreover, given that human and mouse NAIP have previously been shown to employ endogenous retroviral long terminal repeats as promoters, exaptation of Alu repeats as additional promoters provides a fascinating illustration of regulatory innovations adopted by a single gene.


Subject(s)
Neuronal Apoptosis-Inhibitory Protein/chemistry , Promoter Regions, Genetic , Short Interspersed Nucleotide Elements , Alu Elements , Animals , DNA Transposable Elements , HeLa Cells , Humans , Mice , Neuronal Apoptosis-Inhibitory Protein/metabolism , Neurons/metabolism , Open Reading Frames , Protein Isoforms , Protein Structure, Tertiary , Retroelements/genetics , Retroviridae/genetics , Tissue Distribution
6.
PLoS Genet ; 3(1): e10, 2007 Jan 12.
Article in English | MEDLINE | ID: mdl-17222062

ABSTRACT

Neuronal apoptosis inhibitory protein (NAIP, also known as BIRC1) is a member of the conserved inhibitor of apoptosis protein (IAP) family. Lineage-specific rearrangements and expansions of this locus have yielded different copy numbers among primates and rodents, with human retaining a single functional copy and mouse possessing several copies, depending on the strain. Roles for this gene in disease have been documented, but little is known about transcriptional regulation of NAIP. We show here that NAIP has multiple promoters sharing no similarity between human and rodents. Moreover, we demonstrate that multiple, domesticated long terminal repeats (LTRs) of endogenous retroviral elements provide NAIP promoter function in human, mouse, and rat. In human, an LTR serves as a tissue-specific promoter, active primarily in testis. However, in rodents, our evidence indicates that an ancestral LTR common to all rodent genes is the major, constitutive promoter for these genes, and that a second LTR found in two of the mouse genes is a minor promoter. Thus, independently acquired LTRs have assumed regulatory roles for orthologous genes, a remarkable evolutionary scenario. We also demonstrate that 5' flanking regions of IAP family genes as a group, in both human and mouse are enriched for LTR insertions compared to average genes. We propose several potential explanations for these findings, including a hypothesis that recruitment of LTRs near NAIP or other IAP genes may represent a host-cell adaptation to modulate apoptotic responses.


Subject(s)
Apoptosis/genetics , Evolution, Molecular , Mammals/genetics , Neuronal Apoptosis-Inhibitory Protein/genetics , Promoter Regions, Genetic/genetics , Retroelements/genetics , Terminal Repeat Sequences/genetics , 5' Flanking Region/genetics , Animals , Base Sequence , Gene Expression Profiling , Humans , Male , Mice , Models, Genetic , Molecular Sequence Data , Rats , Transcription, Genetic
7.
PLoS Genet ; 2(1): e2, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16440055

ABSTRACT

The inbred mouse is an invaluable model for human biology and disease. Nevertheless, when considering genetic mechanisms of variation and disease, it is important to appreciate the significant differences in the spectra of spontaneous mutations that distinguish these species. While insertions of transposable elements are responsible for only approximately 0.1% of de novo mutations in humans, the figure is 100-fold higher in the laboratory mouse. This striking difference is largely due to the ongoing activity of mouse endogenous retroviral elements. Here we briefly review mouse endogenous retroviruses (ERVs) and their influence on gene expression, analyze mechanisms of interaction between ERVs and the host cell, and summarize the variety of mutations caused by ERV insertions. The prevalence of mouse ERV activity indicates that the genome of the laboratory mouse is presently behind in the "arms race" against invasion.


Subject(s)
Endogenous Retroviruses/genetics , Mutagenesis , Animals , Drosophila , Gene Silencing , Genetic Techniques , Genome , Germ Cells , Humans , Mice , Mice, Inbred C57BL , Models, Biological , Mutation , RNA Processing, Post-Transcriptional
8.
Gene ; 366(2): 335-42, 2006 Feb 01.
Article in English | MEDLINE | ID: mdl-16288839

ABSTRACT

Eight percent of the human genome is derived from endogenous retrovirus (ERV) insertions. ERV long terminal repeats (LTRs) contain strong promoters that are known to contribute to the transcriptional regulation of certain human genes. While some LTRs are known to possess bidirectional promoter activity in vitro, only sense orientation LTR promoters have previously been shown to regulate human gene expression. Here we demonstrate that an ERV1 LTR acts as a bidirectional promoter for the human Down syndrome critical region 4 (DSCR4) and DSCR8 genes. We show that while DSCR4 and DSCR8 are essentially co-expressed, their shared LTR promoter is more active in the sense than the antisense orientation. Through deletion analysis of the LTR we have identified positive and negative regulatory elements, and defined a core region of the promoter that is required for transcriptional activity in both orientations. Finally, we show that the ERV LTR also exists in the genomes of several non-human primates, and present evidence that potential transcription factor binding sites in the core region have been maintained throughout primate evolution.


Subject(s)
Antigens, Neoplasm/genetics , Genome, Human , Pregnancy Proteins/genetics , Promoter Regions, Genetic/genetics , Terminal Repeat Sequences/genetics , Transcription, Genetic/genetics , Binding Sites/genetics , Down Syndrome/genetics , Gene Expression Regulation/genetics , Humans , RNA, Long Noncoding , Retroviridae/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...